Slide 1: Half-Year Results 2026
TBU Half-Year Results 2026 Media and Investor Webcast July 17, 2026 Delivering Growth – in Asia and Beyond. Page 1
Slide 2: Agenda
Agenda 1. Highlights H1 2026 2. Business Units Review 3. Financial Update 4. Outlook Page 2
Slide 3: Highlights H1 2026
ill Highlights H12026 —= — en
Slide 4: Consistent Execution of Our Mid-Term Roadmap
Consistent Execution of Our Mid-Term Roadmap Higher Core EBIT ¹ Growth Margin Expansion M&A Roadmap Mid-Term 329.9 Structural Organic Operational tailwinds + execution + excellence + Portfolio mix + Enlargefootprint geographic + Expand offering 2023 Mid-Term Net Sales Growth (CER1) H1 Core EBIT Marg
Slide 5: DKSH Delivers Accelerated Growth, Strong Cash Conversion, and Higher EPS
DKSH Delivers Accelerated Growth, Strong Cash Conversion, and Higher EPS ‒ Reaffirming Resilience in Uncertain Times DKSH Mid-Term Roadmap KPIs H1 2026 Realization Deliver accelerated net sales Growth Net Sales: +4.9% at CER3 growth above GDP1,2 Margin Expand margin on average by Core EBIT: +3.6% at
Slide 6: Driving Value Through Sustained Commercial Momentum and Continuous Improvement
Driving Value Through Sustained Commercial Momentum and Continuous Improvement New and Expansion Operational Excellence & Artificial Sustainability of Business* High-Performance Culture Intelligence • Continued strong Employee • AI as Core Value Driver with • Approval From SBTi for Emissions Engagem
Slide 7: AI Enables Growth, Operational Excellence, Workforce Transformation, And New Business Opportunities
AI Enables Growth, Operational Excellence, Workforce Transformation, And New Business Opportunities • AI-driven customer prioritization and salesforce • AI-driven project to automate high-volume order optimization system (Polaris AI) management and fulfillment processes • Launch in Singapore in Q3;
Slide 8: Business Units Review
2 Business Units Review Page 8
Slide 9: Business Unit Healthcare
Business Unit Healthcare Net Sales (in CHF million) • Sustained net sales growth momentum +4.9%1 • Broad-based, above-GDP growth across markets 2’889.5 2’858.5 • Very strong business development (e.g. Eli Lilly, Pfizer, Sanofi, BridgeBio), higher share of Commercial Outsourcing • Development in inno
Slide 10: Acceleration of Profitable Growth in Healthcare Through Business Development and M&A
Acceleration of Profitable Growth in Healthcare Through Business Development and M&A Focus Area Distribution & Own Logistics Commercial Outsourcing Brands Accelerating Growth Through Business Development Full License / • Commercial Outsourcing remains a key growth driver, supported 3PL 4PL CSO CSMO
Slide 11: Business Unit Consumer Goods
Business Unit Consumer Goods Net Sales (in CHF million) • Accelerated net sales growth (at CER) • Momentum in key markets, e.g. Thailand, +3.4%1 Malaysia, Vietnam, and Singapore 1’686.6 1’666.7 • Accelerated new client wins e.g. Nestlé, Kellanova, KraftHeinz, Unicharm • Temporary gross margin diluti
Slide 12: Business Unit Performance Materials
Business Unit Performance Materials Net Sales (in CHF million) • Net Sales growth of 8.4% with sequential improvement +8.4%1 • Continued strong performance in 698.0 707.9 Asia Pacific (15.2% at CER) • Robust business development pipeline • Acquisitions contributed to results H1 2025 H1 2026 positive
Slide 13: Business Unit Technology
Business Unit Technology • Solid top line development Net Sales (in CHF million) • Higher share of Scientific Solutions +4.7%1 • Strong development in Semiconductor / Electronics 246.9 237.9 • Robust performance of Precision Machinery • Growth of services and consumables – in line with strategy H1 2
Slide 14: Financial Update
3 Financial Update Page 14
Slide 15: H1 2026 – Continued Financial Performance, Delivering an EPS Uplift of 10.6%
H1 2026 – Continued Financial Performance, Delivering an EPS Uplift of 10.6% Net Sales Core EBIT Core EBIT Margin Core Profit After Tax Free Cash Flow (in CHF billion) (in CHF million) (in %) (in CHF million) (in CHF million) Cash Conversion (%) +4.9%1 +3.6%1 -10 bps +12.9%1 117.5% 130.8% (Approx. h
Slide 16: Accelerated Top Line Growth and EBIT Increase with Strong FX Impact
Accelerated Top Line Growth and EBIT Increase with Strong FX Impact Net Sales (in CHF million) Core EBIT (in CHF million) 4.1% 0.8% 2.5% 5’520.8 169.3 1.1% 5’470.9 163.4 (3.3)% 158.0 (5.8%) +4.9%1 +3.6%¹ (7.1)% 2 H1 2025 Organic Net M&A FX H1 2026 H1 2025 Organic Net M&A FX H1 2026 Non-core H1 2026
Slide 17: Sustainable Net Sales and Core EBIT Increase Since 2022
Sustainable Net Sales and Core EBIT Increase Since 2022… Net Sales Core EBIT2 (in CHF billion) (in CHF million) CAGR +4.3%1 CAGR +8.2%1 6.3 6.6 6.0 6.2 209.9 191.0 202.4 177.3 162.6 163.6 169.3 163.4 153.3 5.6 5.6 5.4 5.5 5.5 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1
Slide 18: Combined With a Legacy of Strong Cash Generation
…Combined With a Legacy of Strong Cash Generation Working Capital1 Free Cash Flow (in % of annualized Net Sales) (in CHF million) Ø Cash Conversion: 124.5% 179.0 160.8 8.6% 147.7 8.0% 7.8% 7.7% 7.8% 121.6 72.1 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 Capex1 / N
Slide 19: Continued Strong Balance Sheet With Significant Leverage Potential
Continued Strong Balance Sheet With Significant Leverage Potential in CHF million 2025 H1 2026 Cash/liquid assets 538.4 503.7 Continued strong return and balance Trade receivables 1,890.9 1,829.5 sheet metrics Inventories 1,254.1 1,366.5 • High Core RONOC of 18.7% Intangibles 801.3 815.2 • Improved
Slide 20: Additional Financial Indications
Additional Financial Indications FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 Mid-Term Estimate1 Estimate Net M&A3 Increased M&A 1.5% 2.1% 0.9% 0.4% ~1%1,2 (net sales contribution) ambitions FX Moderate (2.6%) (7.5%) (3.8%) (3.1%) n.a. (net sales contribution) headwind2 Tax Rate 27.1% 28.1% 29.5% 28.7% 2
Slide 21: Outlook
4 Outlook Page 21
Slide 22: Outlook – Consistently Delivering on Our Results
Outlook – Consistently Delivering on Our Results Current Macroeconomic Landscape Prospects for 2026 and Beyond Change picture • Recent forecasts point to resilient GDP • DKSH is committed to its mid-term growth in 20261 roadmap, highlighting that its outlook for • Emerging and developing Asia contin
Slide 23: Disclaimer
Disclaimer While this presentation has been prepared by DKSH with due care and based on information it reasonably believes to be accurate, complete and up-to-date on the date hereof, this presentation may be inaccurate or incomplete or contain typographical errors or information that is not up-to-da